Kane Biotech Inc.
OTC: KNBIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Huizinga
- Employees
- 20
- Headquarters
- Winnipeg, Canada
- IPO year
- 2007
- Market cap
- $4.4M
- Website
- https://kanebiotech.com
Loading KNBIF…
Loading profile data…Frequently asked questions about KNBIF
What does Kane Biotech Inc. (KNBIF) do?
Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB fo...
Where does KNBIF trade?
Kane Biotech Inc. (KNBIF) trades on the Other OTC.
What sector is KNBIF in?
Kane Biotech Inc. (KNBIF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kane Biotech Inc.?
Robert Huizinga is the chief executive officer of Kane Biotech Inc. (KNBIF).
Where is Kane Biotech Inc. headquartered?
Kane Biotech Inc. is headquartered in Canada.
Does KNBIF pay a dividend?
Kane Biotech Inc. (KNBIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KNBIF go public?
Kane Biotech Inc. (KNBIF) completed its initial public offering in 2007.